# Editas Medicine, Inc. — Form D

Editas Medicine, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-18. The offering totals $120.0M, of which $120.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-08-18
- Form: D
- Accession: 0001650664-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $120.0M
- Amount sold: $120.0M
- Investors: 43
- Date of first sale: 2015-08-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-245968

## Issuer

- Name: Editas Medicine, Inc.
- CIK: 0001650664
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 300 THIRD STREET, CAMBRIDGE, MA, 02142
- Phone: 617-401-9000

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Kevin Bitterman | Director | Cambridge, MA |
| Alexis Borisy | Director | Boston, MA |
| KATRINE BOSLEY | Director | CAMBRIDGE, MA |
| Douglas Cole | Director | Cambridge, MA |
| Boris Nikolic | Director | Atlanta, GA |
| KATRINE BOSLEY | Executive Officer | CAMBRIDGE, MA |
| Alexandra Glucksmann | Executive Officer | Medford, MA |
| Andrew Hack | Executive Officer | CAMPBELL, CA |
| VIC MYER | Executive Officer | BOSTON, MA |

## More

- [CIK 1650664 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1650664&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001650664-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.